![]() | |
![]() | |
Clinical data | |
---|---|
Trade names | Cloxapen, others |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Routes of administration | By mouth, IM |
ATC code | |
Pharmacokinetic data | |
Bioavailability | 37 to 90% |
Protein binding | 95% |
Elimination half-life | 30 minutes to 1 hour |
Excretion | kidney and biliary |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.468 |
Chemical and physical data | |
Formula | C19H18ClN3O5S |
Molar mass | 435.88 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Cloxacillin is an antibiotic useful for the treatment of several bacterial infections. [1] This includes impetigo, cellulitis, pneumonia, septic arthritis, and otitis externa. [1] It is not effective for methicillin-resistant Staphylococcus aureus (MRSA). [2] It can be used by mouth and by injection. [1]
Side effects include nausea, diarrhea, and allergic reactions including anaphylaxis. [1] Clostridioides difficile diarrhea may also occur. [2] It is not recommended in people who have previously had a penicillin allergy. [1] Use during pregnancy appears to be relatively safe. [1] Cloxacillin is in the penicillin family of medications. [2]
Cloxacillin was patented in 1960 and approved for medical use in 1965. [3] It is on the World Health Organization's List of Essential Medicines. [4] It is not commercially available in the United States. [2]
It is semisynthetic and in the same class as penicillin. Cloxacillin is used against staphylococci that produce beta-lactamase, due to its large R chain, which does not allow the beta-lactamases to bind. This drug has a weaker antibacterial activity than benzylpenicillin, and is devoid of serious toxicity except for allergic reactions.[ citation needed ]
Cloxacillin was discovered and developed by Beecham (now GlaxoSmithKline). [5]
It is sold under a number of trade names, including Cloxapen, Cloxacap, Tegopen and Orbenin. [6]